Top compounds associated with response to ADGRF5


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC -0.087 0.05
mRNA tivozanib GDSC1000 pan-cancer AAC -0.022 0.5
mRNA tivozanib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.018 0.6
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.062 0.04
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.0054 0.9
mRNA triptolide CTRPv2 pan-cancer AAC -0.045 0.2
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.014 0.8
Download CSV